Phathom Pharmaceuticals | 4:持股变动声明-董事 Topper James N
Phathom Pharmaceuticals | 4:持股变动声明-董事 Parikh Asit
Phathom Pharmaceuticals | 4:持股变动声明-董事 COLA MICHAEL F
Phathom Pharmaceuticals | 4:持股变动声明-董事 FIELDS HEIDI
Phathom Pharmaceuticals | 4:持股变动声明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4:持股变动声明-董事 Stenhouse Mark
Phathom Pharmaceuticals | 4:持股变动声明-董事 Socks David A
Phathom Pharmaceuticals | 8-K:重大事件
Phathom Pharmaceuticals | 10-Q:季度报表
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公布2024年第一季度财务业绩并提供业务最新情况
Phathom Pharmaceuticals | DEF 14A:股东委托书决议
Phathom Pharmaceuticals | DEFA14A:其他
Phathom Pharmaceuticals | ARS:年度报告
Phathom Pharmaceuticals | 4:持股变动声明-高管 Henderson Molly
Phathom Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Takeda Pharmaceutical Company Limited(4.8%)
Phathom Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Takeda Pharmaceutical Company Limited(5.4%)
Phathom Pharmaceuticals | 4:持股变动声明-高管 Curran Terrie
Phathom Pharmaceuticals | 10-K:年度报表
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公布2023年第四季度和全年财务业绩并提供业务最新情况
Phathom Pharmaceuticals | 8-K:重大事件
暂无数据